1.Association of Biomarker Levels with Severity of Asbestos-Related Diseases.
Eun Kee PARK ; Deborah H YATES ; Jenette CREANEY ; Paul S THOMAS ; Bruce W ROBINSON ; Anthony R JOHNSON
Safety and Health at Work 2012;3(1):17-21
OBJECTIVES: Asbestos-related diseases (ARDs) have increased globally over the decades, causing an economic burden and increased health care costs. It is difficult to predict the risk of development of ARDs and of respiratory disability among workers with a history of asbestos exposure. Blood based biomarkers have been reported as promising tools for the early detection of malignant mesothelioma. This study investigated whether serum soluble mesothelin-related peptide (SMRP) would reflect severity of disablement in compensable ARDs. METHODS: SMRP levels were measured in a cohort of 514 asbestos-exposed subjects. Severity of ARDs was assessed by a Medical Authority comprising four specially qualified respiratory physicians. Severity of ARDs and SMRP levels were compared. RESULTS: Mean (standard deviation) serum SMRP level in the population with compensable ARDs (n = 150) was 0.95 (0.65) nmol/L, and was positively associated with disability assessment (p = 0.01). Mean SMRP level in healthy asbestos-exposed subjects was significantly lower than those with pleural plaques (p < 0.0001) and in subjects with ARDs who received compensation (p < 0.01). CONCLUSION: This study indicates that serum SMRP levels correlate with severity of compensable ARDs. Serum SMRP could potentially be applied to monitor progress of ARDs. Further prospective work is needed to confirm the relationship between SMRP and disability assessment in this population.
Asbestos
;
Biomarkers
;
Cohort Studies
;
Compensation and Redress
;
Health Care Costs
;
Mesothelioma
;
Organothiophosphorus Compounds
2.Follow-up of Soluble Mesothelin-Related Protein Levels in Participants With Asbestos-Related Disorders
Author links open overlay panelEun-Kee PARK ; Anthony R. JOHNSON ; Donald WILSON ; Paul S. THOMAS ; Deborah H. YATES
Safety and Health at Work 2020;11(4):425-430
Background:
Asbestos exposure is associated with the development of the cancer malignant mesothelioma (MM). Measurement of soluble mesothelin-related protein (SMRP) has been suggested as a method for detection of MM in its early stages. We prospectively examined SMRP levels in participants with asbestos exposure who are a group at a high risk of development of MM.
Methods:
This study was a follow-up of our cohort of 322 asbestos-exposed participants. No further participants developed MM or malignancy over the study period. Mean follow-up time was 22.9 months.
Results:
Mean (standard deviation) SMRP levels at baseline and follow-up were 0.94 (0.79) and 0.91 (0.86) nmol/L (p = 0.1033), respectively. Mean SMRP levels of the healthy individuals exposed to asbestos at baseline was significantly lower than those of participants with asbestosis and pleural plaques alone; similar patterns were found on follow-up measurements. There was a statistically significant effect of age on serial SMRP measurements. Our study confirms higher levels in participants with nonmalignant asbestos-related disorders. Levels decreased in asbestos-related disorders other than asbestosis, where a small increase was observed. We did not detect any further cases of malignancy.
Conclusion
Monitoring programs for early detection of MM need to take into account increased SMRP levels found in benign asbestos-related diseases.
3.Follow-up of Soluble Mesothelin-Related Protein Levels in Participants With Asbestos-Related Disorders
Author links open overlay panelEun-Kee PARK ; Anthony R. JOHNSON ; Donald WILSON ; Paul S. THOMAS ; Deborah H. YATES
Safety and Health at Work 2020;11(4):425-430
Background:
Asbestos exposure is associated with the development of the cancer malignant mesothelioma (MM). Measurement of soluble mesothelin-related protein (SMRP) has been suggested as a method for detection of MM in its early stages. We prospectively examined SMRP levels in participants with asbestos exposure who are a group at a high risk of development of MM.
Methods:
This study was a follow-up of our cohort of 322 asbestos-exposed participants. No further participants developed MM or malignancy over the study period. Mean follow-up time was 22.9 months.
Results:
Mean (standard deviation) SMRP levels at baseline and follow-up were 0.94 (0.79) and 0.91 (0.86) nmol/L (p = 0.1033), respectively. Mean SMRP levels of the healthy individuals exposed to asbestos at baseline was significantly lower than those of participants with asbestosis and pleural plaques alone; similar patterns were found on follow-up measurements. There was a statistically significant effect of age on serial SMRP measurements. Our study confirms higher levels in participants with nonmalignant asbestos-related disorders. Levels decreased in asbestos-related disorders other than asbestosis, where a small increase was observed. We did not detect any further cases of malignancy.
Conclusion
Monitoring programs for early detection of MM need to take into account increased SMRP levels found in benign asbestos-related diseases.
4.Knowledge, attitudes, and practices in colorectal cancer screening in the Philippines
Joseff Karl U. Fernandez ; Martin Augustine B. Borlongan ; Michael Anthony A. Baliton ; Dennis L. Sacdalan ; Florge Francis A. Sy ; Analigaya R. Agoncillo ; Carl Lawrence C. Arenos ; Vincent F. Tatoy ; Timothy Joseph S. Uy ; Isabela Andrea L. Reveldez ; Steven Johnson L. Lim
Acta Medica Philippina 2024;58(Early Access 2024):1-15
Background and Objective:
Colorectal cancer (CRC) has the third highest incidence in the Philippines. Currently,
there is a paucity in literature that is focused on the knowledge, attitudes, and perceptions of Filipinos regarding CRC screening. This is the first study in the Philippines that describes this.
Methods:
This is a cross-sectional study that validated a 52-item Filipino questionnaire on the knowledge on
colorectal cancer, willingness to undergo CRC screening, and perceived benefits and barriers to fecal occult blood test (FOBT) and colonoscopy. The study enrolled household heads more than 20 years of age residing in both urban and rural communities in the Philippines.
Results:
The UP-PGH CRC KAP (University of the Philippines – Philippine General Hospital Colorectal Cancer
Knowledge, Attitudes, and Practices) and Rawl Questionnaire’s validity and internal consistency were established in a pilot study of 30 respondents. A total of 288 respondents were then enrolled to the main study group with a median age of 54.0. Knowledge scores for prognosis and utility of CRC screening were modest (6.3/12 and 8.4/20, respectively). Perceived benefit scores to FOBT and colonoscopy were high (9.9/12 and 13.9/16, respectively).Median scores to barriers to FOBT and colonoscopy were intermediate (22.5/36 and 35.8/60, respectively). Notably, a vast majority (86.1%) were willing to participate in CRC screening programs initiated by the government, and 46.9% agreed to undergo screening tests even as out-of-pocket expense.
Conclusion
The UP-PGH CRC KAP Questionnaire as well as the Filipino translation of the Rawl Questionnaire
are reliable and valid tools in extensively assessing the knowledge of Filipinos on CRC and willingness to undergo screening, as well as the benefits of and barriers to FOBT and colonoscopy. Knowledge scores were modest suggesting that directed educational campaigns and awareness programs can aid in increasing awareness about CRC and its screening. Household income and highest educational attainment were significantly positively correlated with knowledge scores, and perceived benefits of and barriers to CRC screening. Scores were generally comparable between urban and rural communities.
Knowledge
;
Attitudes